Clinical Trials
11
Active:0
Completed:8
Trial Phases
2 Phases
Phase 1:3
Phase 2:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 2
7 (70.0%)Phase 1
3 (30.0%)Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 11
- Registration Number
- NCT01078922
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸Oncology Specialists, S.C, Niles, Illinois, United States
🇺🇸Oncology Specialists, S.C., Park Ridge, Illinois, United States
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 21
- Registration Number
- NCT00919035
- Locations
- 🇺🇸
Oncology Specialists, SC, Niles, Illinois, United States
🇺🇸Oncology Specialists, S.C., Park Ridge, Illinois, United States
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
Completed
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2014-07-01
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 50
- Registration Number
- NCT00902434
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2014-03-28
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 32
- Registration Number
- NCT00654186
- Locations
- 🇺🇸
Oncology Specialists, S.C, Park Ridge, Illinois, United States
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
- First Posted Date
- 2007-01-19
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Oncology Specialists, S.C.
- Target Recruit Count
- 17
- Registration Number
- NCT00424385
- Locations
- 🇺🇸
Oncology Specialists, S.C, Park Ridge, Illinois, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found